Trading Update
H1 25 revenue up 35% total and 17% organic; Q1 and Q2 both record quarters.
vs expectations: in line
- H1 25 revenue growth 35% in total
- H1 25 organic revenue growth 17% (prior compared to H1 24)
- Record revenue months in H1 25 five
Select text to share a quote on X · sign in to keep highlights & notes in your ELIX notes
Elixirr International plc ("Elixirr", the "Company" or, together with its subsidiary undertakings, the "Group"), an established, global award-winning challenger consultancy, is pleased to provide a trading update following the end of the six-month period ended 30 June 2025 ("H1 25").
The Group continues to trade strongly. In its annual results announcement on 28 April 2025, the Board confirmed that Q1 2025 had been a record revenue quarter for the Group. Since that announcement, Q2 2025 has also been a record revenue quarter for the Group with five record revenue months during the six-month period. During H1 25, revenue increased by 35% in total and by 17% on an organic basis compared to the comparable period during 2024. Year to date profitability margins are consistent with those achieved in recent years.
The Board remains confident that results for full year FY 2025 will be in line with market expectations.
The Group will announce its interim results for the six months ended 30 June 2025 on 22 September 2025.
Stephen Newton, Founder and Chief Executive Officer, commented:
"We are pleased to report continued growth in H1 25, maintaining our track record of profitable growth since our AIM IPO. Following the recent move to the Main Market of the London Stock Exchange, we look forward to completing the remainder of 2025 with confidence."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.